People will keep eating Oreos despite Ozempic surge, according to CEO of maker, Mondelez

Dirk Van De Put, chairman and chief executive officer of Mondelez International.
Dirk Van De Put, chairman and chief executive officer of Mondelez International.
Kyle Grillot/Bloomberg via Getty Images

Even with appetite-suppressing drugs, people will keep eating Oreo cookies, according to the company that makes them.

Mondelez International Inc., which also makes Sour Patch Kids candy and Ritz crackers, is monitoring the impact of Ozempic and other GLP-1 drugs “quite carefully,” Chief Executive Officer Dirk van de Put said in an interview with Bloomberg TV.

Models that incorporate changes in behavior from the drugs and expected adoption rates predict only a modest impact on its sales, he added. “Those models predict that in 10 years’ time, it will have an effect between 0.5% and 1% of our volume,” he said, calling it a “margin of error.”

Fortune Global Forum returns Oct. 26–27, 2025 in Riyadh. CEOs and global leaders will gather for a dynamic, invitation-only event shaping the future of business. Apply for an invitation.